1
|
Ibricevic A, Guntsen SP, Zhang K, Shrestha R, Liu Y, Sun JY, Welch MJ, Wooley KL, Brody SL. PEGylation of cationic, shell-crosslinked-knedel-like nanoparticles modulates inflammation and enhances cellular uptake in the lung. Nanomedicine 2013; 9:912-22. [PMID: 23453959 PMCID: PMC3724762 DOI: 10.1016/j.nano.2013.02.006] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/17/2012] [Revised: 02/07/2013] [Accepted: 02/18/2013] [Indexed: 11/30/2022]
Abstract
The airway provides a direct route for administration of nanoparticles bearing therapeutic or diagnostic payloads to the lung, however optimization of nanoplatforms for intracellular delivery remains challenging. Poly(ethylene glycol) (PEG) surface modification improves systemic performance but less is known about PEGylated nanoparticles administered to the airway. To test this, we generated a library of cationic, shell crosslinked knedel-like nanoparticles (cSCKs), including PEG (1.5 kDa PEG; 2, 5, 10 molecules/polymer arm) on the outer shell. Delivery of PEGylated cSCK to the mouse airway showed significantly less inflammation in a PEG dose-dependent manner. PEGylation also enhanced the entry of cSCKs in lung alveolar epithelial cells and improved surfactant penetration. The PEGylation effect could be explained by the altered mechanism of endocytosis. While non-PEGylated cSCKs used the clathrin-dependent route for endocytosis, entry of PEGylated cSCK was clathrin-independent. Thus, nanoparticle surface modification with PEG represents an advantageous design for lung delivery. FROM THE CLINICAL EDITOR In this study, the effects of PEGylation were studied on cross linked knedel-like nanoparticles in drug delivery through the lungs, demonstrating less airway inflammation in the studied model than with non-PEGylated nanoparticles, which suggests an overall favorable profile of PEGylated nanoparticles for alveolar delivery.
Collapse
Affiliation(s)
- Aida Ibricevic
- Department of Internal Medicine, Washington University, St. Louis, MO, 63110, USA
| | - Sean P. Guntsen
- Department of Internal Medicine, Washington University, St. Louis, MO, 63110, USA
| | - Ke Zhang
- Department of Chemistry, Washington University, St. Louis, MO, 63110, USA
| | - Ritu Shrestha
- Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA
| | - Yongjian Liu
- Department of Radiology, Washington University, St. Louis, MO, 63110, USA
| | - Jing Yi Sun
- Department of Internal Medicine, Washington University, St. Louis, MO, 63110, USA
| | - Michael J. Welch
- Department of Radiology, Washington University, St. Louis, MO, 63110, USA
| | - Karen L. Wooley
- Department of Chemistry, Washington University, St. Louis, MO, 63110, USA
- Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA
| | - Steven L. Brody
- Department of Internal Medicine, Washington University, St. Louis, MO, 63110, USA
- Department of Radiology, Washington University, St. Louis, MO, 63110, USA
| |
Collapse
|